HRV Pharma and Haleos Labs have joined forces in a multi-year strategic partnership to fast-track the development and manufacturing of specialized active pharmaceutical ingredients (APIs) for rare diseases and niche therapies. This collaboration leverages HRV's global market access and Haleos' manufacturing expertise to introduce 5-7 new high-value molecules annually, targeting underserved patient populations worldwide.
Read full article
Comments (0)